High Point Advisor Group LLC Amgen Inc Transaction History

High Point Advisor Group LLC

$1.67 Billion
Q3 2024

A detailed history of High Point Advisor Group LLC transactions in Amgen Inc stock. As of the latest transaction made, High Point Advisor Group LLC holds 12,611 shares of AMGN stock, worth $3.57 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

12,611

Previous 12,505 0.85%

Holding current value

$3.57 Million

Previous $3.91 Million 3.99%

% of portfolio

0.24%

Previous 0.22%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$309.38 - $337.38 $32,794 - $35,762	106 Added 0.85%	12,611 $4.06 Million
Q2 2024 Aug 08, 2024	BUY	$262.75 - $319.31 $327,912 - $398,498	1,248 Added 11.09%	12,505 $3.91 Million
Q1 2024 May 14, 2024	BUY	$268.87 - $324.56 $89,533 - $108,078	333 Added 3.05%	11,257 $3.2 Million
Q4 2023 Mar 26, 2024	SELL	$255.7 - $288.46 $59,066 - $66,634	-231 Reduced 2.07%	10,924 $3.15 Million
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $694,206 - $772,530	-3,009 Reduced 21.24%	11,155 $2.74 Million
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $138,824 - $162,649	654 Added 4.84%	14,164 $3.01 Million
Q2 2021 Jul 29, 2021	BUY	$233.58 - $259.14 $247,361 - $274,429	1,059 Added 8.51%	13,510 $3.29 Million
Q1 2021 Apr 12, 2021	SELL	$221.91 - $258.6 $43,716 - $50,944	-197 Reduced 1.56%	12,451 $3.1 Million
Q4 2020 Feb 10, 2021	BUY	$216.38 - $257.67 $1.68 Million - $2 Million	7,747 Added 158.07%	12,648 $2.99 Million
Q3 2020 Nov 06, 2020	SELL	$234.65 - $260.95 $98,083 - $109,077	-418 Reduced 7.86%	4,901 $1.14 Million
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $61,321 - $75,249	310 Added 6.19%	5,319 $1.36 Million
Q1 2020 May 01, 2020	BUY	$182.24 - $241.7 $697,250 - $924,744	3,826 Added 323.42%	5,009 $1.18 Million
Q1 2020 Apr 27, 2020	SELL	$182.24 - $241.7 $1.2 Million - $1.59 Million	-6,589 Reduced 84.78%	1,183 $5.01 Million
Q4 2019 Feb 13, 2020	BUY	$189.21 - $243.2 $529,031 - $679,987	2,796 Added 56.19%	7,772 $1.85 Million
Q3 2019 Nov 12, 2019	SELL	$174.11 - $208.62 $108,818 - $130,387	-625 Reduced 11.16%	4,976 $1.1 Million
Q2 2019 Aug 15, 2019	SELL	$166.7 - $195.41 $12,335 - $14,460	-74 Reduced 1.3%	5,601 $985,000
Q1 2019 May 08, 2019	SELL	$180.87 - $203.88 $232,598 - $262,189	-1,286 Reduced 18.47%	5,675 $986,000
Q4 2018 Feb 20, 2019	BUY	$178.4 - $208.25 $145,039 - $169,307	813 Added 13.22%	6,961 $1.3 Million
Q3 2018 Oct 24, 2018	SELL	$185.29 - $208.89 $12,970 - $14,622	-70 Reduced 1.13%	6,148 $1.22 Million
Q2 2018 Aug 20, 2018	BUY	$166.05 - $186.51 $283,115 - $317,999	1,705 Added 37.78%	6,218 $1.22 Million
Q1 2018 Jun 11, 2018	SELL	$169.43 - $198.0 $353,939 - $413,622	-2,089 Reduced 31.64%	4,513 $832,000
Q4 2017 Feb 15, 2018	SELL	$168.79 - $188.59 $26,500 - $29,608	-157 Reduced 2.32%	6,602 $1.16 Million
Q3 2017 Nov 06, 2017	BUY	$167.29 - $191.0 $1.13 Million - $1.29 Million	6,759	6,759 $1.17 Million

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $151B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of High Point Advisor Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Point Advisor Group LLC with notifications on news.

Account

High Point Advisor Group LLC Amgen Inc Transaction History